An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Postmarket Drug Safety Information for Patients and Providers

Information on Abacavir (marketed as Ziagen) and Abacavir-containing Medications

Abacavir is an antiviral medication used in combination with other antiretroviral drugs for the treatment of HIV-1 infection.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.

Related Information

FDA Drug Safety Communication: Safety Review update of Abacavir and possible increased risk of heart attack

Labeling and Regulatory History from Drugs@FDA

Top